The agency issued a rule that brings new scrutiny to a range of critical lab-developed tests, including certain cancer and prenatal screenings. ProPublica previously reported how lab-test accuracy and marketing had skirted federal oversight.

Medical lab tests developed by private labs, hospitals and universities will be placed under FDA oversight within the next four years The new rule doesn't apply to tests from major private companies;